The study found that a network called the ‘frontostriatal salience network’ was expanded in people with depression. This ...

A new study published in the journal of Public Library of Science found that the triglyceride levels of individuals with ...

New research underscores the role of the immune system in depression, linking inflammation to poor response to standard antidepressants and highlighting the importance of personalized medicine in ...

A brain network involved in motivation and attention is larger in people with depression. The difference is also visible in ...

The app, called Rejoyn, is cleared as a supplement to currently approved therapies and works by using specifically designed ...

This study highlights the efficacy of home-based tDCS in treating major depressive disorder, with significant improvements in ...

Alto Neuroscience's ALTO-100 Phase 2b study for major depressive disorder failed to meet its primary endpoint, but the ...

Researchers found that a 10-week course of home-based transcranial direct current stimulation (tDCS) significantly improved ...

If you’re feeling depressed and looking for a solution, there are many options: medications, CBT, DBT, somatic therapy and so ...

Background: Depressive disorders are highly prevalent, have a detrimental impact on the quality of life of patients and their relatives and are associated with increased mortality rates ...

Major depressive disorder (MDD) is a chronic and recurrent mental condition leading to huge impacts on direct and indirect personal and public medical costs. To overcome such a serious mental ...

Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that ...